1. Disposition of oral clarithromycin in foals.
- Author
-
Jacks S, Giguère S, Gronwall RR, Brown MP, and Merritt KA
- Subjects
- Actinomycetales Infections drug therapy, Actinomycetales Infections veterinary, Administration, Oral, Animals, Animals, Newborn metabolism, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents blood, Anti-Bacterial Agents therapeutic use, Area Under Curve, Clarithromycin administration & dosage, Clarithromycin blood, Clarithromycin therapeutic use, Female, Horse Diseases drug therapy, Male, Microbial Sensitivity Tests, Anti-Bacterial Agents pharmacokinetics, Anti-Bacterial Agents pharmacology, Clarithromycin pharmacokinetics, Clarithromycin pharmacology, Horses metabolism, Rhodococcus equi drug effects
- Abstract
Clarithromycin offers numerous advantages over erythromycin and thus, is an attractive alternative for the treatment of Rhodococcus equi infections in foals. The disposition of clarithromycin was investigated in 6 foals after intragastric administration at a dose of 10 mg/kg body weight. Detectable serum concentrations of clarithromycin were found in 3 of 6 foals at 10 minutes and in all foals by 20 minutes post-administration. Time to peak serum concentration (Tmax) was 1.5 hours and peak serum concentration (Cmax) was 0.92+/-0.17 microg/ml. Mean serum concentrations decreased to 0.03 microg/ml at 24 h. No adverse reactions were noted during or after IG administration in any of the foals. Based on the pharmacokinetic parameters, the MIC90 of R. equi isolates, and predicted steady state concentrations, an oral dose of 7.5 mg/kg given every 12 hours would appear appropriate for the treatment of R. equi infections in foals.
- Published
- 2002
- Full Text
- View/download PDF